MedPath

Quality of life and drug therapy management in women with PCOS

Not Applicable
Conditions
Health Condition 1: N948- Other specified conditions associated with female genital organs and menstrual cycle
Registration Number
CTRI/2022/02/040243
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Out-patients of Department of Obstetrics & Gynaecology and IVF Center Kshema, Department of Endocrinology, Department of Dermatology. Women aged 15-45 years, Patients with physical symptoms of PCOS, Women with biochemical abnormalities or polycystic ovaries visualized in ultra sound, Patients who are willing to participate in the study.

Exclusion Criteria

Women who are not willing to Participate, Patients who provide incomplete information.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The study aims to learn the upcoming need for specific, overall and multimode treatment provided by practitioners from different disciplines.Timepoint: Date of Hospital Visit.
Secondary Outcome Measures
NameTimeMethod
To assess the influence of PCOS on HRQoL.Timepoint: Date of Hospital Visit.
© Copyright 2025. All Rights Reserved by MedPath